Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Implementation of an IV-oral Switch Policy to Treat Proven or Suspected Infections Due to Resistant Gram Positive Bacteria in a London Hospital Trust

NCT00501150 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT00501150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00501150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Implementation of an IV-oral Switch Policy to Treat Proven or Suspected Infections Due to Resistant Gram Positive Bacteria in a London Hospital Trust
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2005
Completion date
June 30, 2007
Enrollment
211 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gram-positive bacterial infections, staphylococcal infections